<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04086836</url>
  </required_header>
  <id_info>
    <org_study_id>SWESTAT</org_study_id>
    <nct_id>NCT04086836</nct_id>
  </id_info>
  <brief_title>Swedish Study on STroke After TAVR</brief_title>
  <acronym>SWESTAT</acronym>
  <official_title>Swedish Study on STroke After TAVR. A Nationwide All-comers Study of the Risk of Stroke After Transcatheter Aortic Valve Replacemant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at studying the frequency of late stroke after transcatheter aortic valve
      replacement/implantation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since the start of transcatheter aortic valve implnatations/replacements (TAVR/TAVI)
      implantations in Sweden in 2008 all procedures have been added to a national database, which
      now contains 5000+ procedures. At the same time, all admissions to the hospital is also
      recorded with diagnosis in a separate database. We intend to make a nation-wide complete
      follow up of all TAVR/TAVI patients in swede that has received the diagnosis of stroke after
      the implantation. In addition data will also be collected from the national stroke database
      for detailed information of the cases
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Actual">February 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Stroke</measure>
    <time_frame>5 year</time_frame>
    <description>Stroke as defined by the national stroke database</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">4600</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Patient suffering a late stroke after TAVR</arm_group_label>
    <description>All patients suffering a stroke after TAVR will be studied</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAVR</intervention_name>
    <description>Patient recieving a TAVR</description>
    <arm_group_label>Patient suffering a late stroke after TAVR</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All pateints recieving a TAVR device in Sweden during study period
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients that has under TAVR/TAVI in Sweden between 2008 and 2018 Exclusion Criteria:
        Patients unable to follow up due to emigration or missing social security number

        Exclusion Criteria:

        Periprocedural stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Skane University Hospital</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2019</study_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TAVR</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

